• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Clobazam

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup 
Labeling Sections with
Pharmacogenomic
Information
ClobazamNeurologyCYP2C19CYP2C19 poor
metabolizers
 
Clinical Pharmacology
Dosage and Administration
Use in Specific Populations

 

back to Table of Pharmacogenomic Biomarkers in Drug Labeling